Oseltamivir-Associated Supraventricular Tachycardia in an Infant
| Autor: | Elizabeth A Boucher, Kelley H Shultz, Emily C Bodo |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pediatrics
medicine.medical_specialty Oseltamivir medicine.drug_class viruses Case Reports 030204 cardiovascular system & hematology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine 030225 pediatrics Heart rate Medicine Pharmacology (medical) Neuraminidase inhibitor business.industry Primary care physician virus diseases Influenza a medicine.disease respiratory tract diseases chemistry Pediatrics Perinatology and Child Health Supraventricular tachycardia Level of care business |
| Zdroj: | J Pediatr Pharmacol Ther |
| ISSN: | 1551-6776 |
| Popis: | Oseltamivir is a neuraminidase inhibitor that is labeled for prophylaxis and treatment of influenza. We describe a previously healthy 4-month-old infant who tested positive for influenza A and was started on oseltamivir. One hour after receiving his first dose of oseltamivir, the infant had a diaphoretic episode and appeared grey and clammy. The infant was subsequently seen by the primary care physician and referred for admission to the hospital. Approximately 40 minutes after the second dose of oseltamivir in the hospital, the infant's heart rate rose to greater than 300 bpm. An electrocardiogram was suggestive of supraventricular tachycardia. At the time of the event, the infant received 2 doses of adenosine, and oseltamivir was discontinued prior to transfer to a tertiary facility for a higher level of care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|